DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Rini BI, Plimack ER, Stus V. , et al; KEYNOTE-426 Investigators.
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma.
N Engl J Med 2019;
380 (12) 1116-1127
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.